Ventyx Biosciences, Inc (VTYX) - Long-Term Debt to Capital Coefficient
Ventyx Biosciences (VTYX) aims to secure a leading position in the oral anti-inflammatory segment as it progresses through clinical trial stages. The linear price action on the GURU.Markets chart confirms the company's current status, where the indicator stands at 0.05. The business develops convenient tablet-based alternatives to injections for treating autoimmune pathologies, while implementing automated software and robotics to accelerate the analysis of medical tests.
%20Long-Term%20Debt%20to%20Capital&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_VTYX_-_Ventyx-Biosciences_-_Long-Term-Debt-to-Capital "VTYX: Ventyx Biosciences, Inc. Long-Term Debt to Capital 07/04/2022 - 03/14/2026 | 👁️GURU.Markets👁️")
Comprehensive metric breakdowns and analytics for Ventyx Biosciences (VTYX)
- stock price and consensus target price:
- market capitalization indicators:
- balance sheet net asset value indicators:
- debt and solvency information:
Total Debt to Equity Ratio Ventyx Biosciences|VTYX - Long-Term Debt to Capital|Short-Term Debt to Capital ventyxbio.com|VTYX - Company Total Debt|Debt to Net Assets Ratio Ventyx Biosciences, Inc.|VTYX - Company Long-Term Debts|Short-Term Debt Volume Ventyx Biosciences|Quick Liquidity Indicator ventyxbio.com
- net income and valuation ratios data:
General company analysis:Ventyx Biosciences Inc. - VTYX
Financial resilience to external shocks is critical for Ventyx Biosciences (VTYX) amid regulatory risks and raw material supply chain vulnerabilities. By analyzing the ratio of long-term debt to equity, an investor assesses the proportion of loans with maturities exceeding one year within the capital structure, which determines the company's level of leverage and its ability to service debt without the risk of default.
Key competitors
argenx N.V. - Long-Term Liabilities to Equity|Long-Term Debt to Capital BNTX|ABVX (Abivax S.A.) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital ADMA (ADMA Biologics)|Long-Term Debt to Capital protagonist-inc.com PTGX|IMVT - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Long-Term Debt to Capital|Long-Term Debt to Capital auriniapharma.com|Long-Term Debt to Equity Ratio BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital DNTH (Dianthus Pharma)|Ratio of Long-Term Indebtedness to Capital Pharvaris Pharma (PHVS)|ABCL - Long-Term Debt to Equity|tourmalinebio.com (TRML) - Long-Term Debt to Equity Ratio|Precigen (PGEN) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Pharming Group NV|Long-Term Debt to Equity Ratio NKTR|Long-Term Debt to Capital Upstream Pharma|Long-Term Debt to Equity Zenas Biopharma Inc (ZBIO)|immunome.com - Long-Term Debt to Capital Ratio|Long-Term Debt to Capital GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Long-Term Liabilities to Capital|SEPN: Long-Term Debt to Equity Ratio|PVLA: Long-Term Debt to Equity|SVRA: Long-Term Debt to Capital|Long-Term Liabilities to Capital rigel.com (RIGL)|Long-Term Debt to Equity AnaptysBio|Long-Term Debt to Capital Ratio ATXS (Astria Therapeutics Inc)|Long-Term Debt to Equity Ratio ENGN (enGene Bio)|Long-Term Loans to Capital Ratio RAPT|Aerovate Therapeutics - Long-Term Debt to Equity Ratio|aclaristx.com (ACRS) - Long-Term Liabilities to Capital|KYTX: Long-Term Debt to Equity Ratio|TLSA (Tiziana Life Sciences Ltd.) - Long-Term Debt to Capital Ratio|CABA (Cabaletta Bio, Inc) - Long-Term Debt to Equity Ratio|Theratechnologies, Inc - Long-Term Debt to Capital Coefficient|AVTX (Avalo Therapeutics, Inc) - Long-Term Debt to Capital|Long-Term Debt to Equity ELDN|Long-Term Debt to Capital AGEN|Ratio of Long-Term Indebtedness to Capital Climb Bio Inc.|Long-Term Debt to Equity Zura Bio Limited ZURA|aTyr Pharmaceuticals (ATYR) - Long-Term Liabilities to Capital|ADAG - Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital ImageneBio Inc IMA|STTK: Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Equillium|CNTB (Connect Biopharma Holdings) - Long-Term Debt to Capital|Immunic Inc (IMUX) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital ATRA|IFRX - Long-Term Liabilities to Capital|Long-Term Debt to Equity X4 Pharmaceuticals, Inc. XFOR|ACET: Long-Term Debt to Capital Ratio|Celularity Corp - Long-Term Debt to Capital|INmune Bio Corporation (INMB) - Long-Term Debt to Equity Ratio|BRNS: Long-Term Debt to Capital|Long-Term Liabilities to Capital kezarlifesciences.com (KZR)|Long-Term Debt to Equity SAB Biotherapeutics, Inc.|Akari Therapeutics PLC (AKTX) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio ENLV (Enlivex Therapeutics)|Long-Term Debt to Equity QTTB (q32bio.com)|GeoVax Labs, Inc. - Long-Term Debt to Equity Ratio|Long-Term Loans to Capital Ratio EDSA (edesabiotech.com)|IBIO: Long-Term Debt to Equity Ratio|Long-Term Liabilities to Capital Carisma Therapeutics|XTLB (XTL Biopharmaceuticals, Ltd.) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Ratio BOLT|Long-Term Debt to Equity HCW Biologics, Inc.|Aptevo - Long-Term Liabilities to Equity|Long-Term Debt to Capital AIM|ADTX (aditxt.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital GRI (GRI Bio Corp)|Long-Term Debt to Capital XORTX Corp XRTX|HIND - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient REVB (revbiosciences.com)|Indaptus Therapeutics, Inc. (INDP) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Scinai Immunotherapeutics Ltd|CALI (CalciMedica Inc) - Long-Term Debt to Capital|Long-Term Debt to Capital Affimed Therapeutics|Long-Term Debt to Equity Ratio ALLK (Allakos Inc.)|HOOK (hookipapharma.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital IGMS (IGM Biosciences)|Ratio of Long-Term Indebtedness to Capital iTeos Therapeutics Inc (ITOS)|OCEA - Long-Term Debt to Equity|TC BioPharm Ltd (TCBP) - Long-Term Debt to Equity Ratio|Third Harmonic Bio (THRD) - Long-Term Debt to Equity